Dogmas & Controversies in Hematologic Malignancies: Los Angeles 2026 conference hero image

Dogmas & Controversies in Hematologic Malignancies: Los Angeles 2026

Accreditation: 10.50 Nursing Contact Hours | 10.50 ABIM MOC II | 10.50 AMA PRA Category 1 Credit™ | 10.50 ACPE Pharmacy

Venue: Sonesta Redondo Beach & Marina, 300 North Harbor Drive, Redondo Beach, CA, 90277, United States

Start Date: End Date:

Official conference page for Dogmas & Controversies in Hematologic Malignancies: Los Angeles 2026.

About Dogmas & Controversies in Hematologic Malignancies: Los Angeles 2026

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

Suyog Kadel
56+

Faculty and committee

Our Speakers

Faculty

Thomas Martin

Thomas Martin, MD

Session Chair

University of California, San Francisco

Matthew Mei

Matthew Mei, MD

Session Chair

City of Hope

Murali Janakiram

Murali Janakiram, MD

Session Chair

CITY OF HOPE

Vinod Pullarkat

Vinod Pullarkat, MD

Session Chair

City of Hope

Michael Rosenzweig

Michael Rosenzweig, MD

Session Chair

Brian Jonas

Brian A Jonas

Session Chair

Jerald Radich

Jerald Radich, MD

Session Chair

Fred Hutch

Anupama Kumar

Anupama Deepa Kumar, MD

Session Chair

University of California, San Francisco

Brian Sworder

Brian Sworder, MD, MD, PhD, PhD

Session Chair

Jonathan Kaufman

Jonathan L Kaufman, MD

Session Chair

Winship Cancer Institute of Emory University

Victor Orellana-Noia

Victor Manuel Orellana-Noia, MD

Faculty

City of Hope

Lihong Wu

Lihong Wu, MD

Faculty

Harsh Shah

Harsh Shah, DO

Faculty

Huntsman Cancer Institute

Robert Carroll

Robert Matthew Carroll, MD

Faculty

Matthew Cortese

Matthew J. Cortese, MD, MPH

Faculty

Roswell Park Comprehensive Cancer Center

Joseph Marshalek

Joseph Patrick Marshalek, MD, MD

Faculty

Harbor-UCLA Medical Center, Division of Hematology and Medical Oncology

Ryotaro Nakamura

Ryotaro Nakamura, MD

Faculty

Idoroenyi Amanam

Idoroenyi Amanam, MD

Faculty

City of Hope

Kwan-Keat Ang

Kwan-Keat Ang, MD, MD

Faculty

UCSF

Amanda Blackmon

Amanda Blackmon, DO

Faculty

City of Hope

Saro Kasparian

Saro Kasparian

Faculty

Holly Lee

Holly Lee, MD

Faculty

Wanxing Chai-Ho

Wanxing Chai-Ho, MD

Faculty

David Geffen School of Medicine at UCLA

Claire Carlson

Claire Carlson, PharmD

Faculty

City of Hope Comprehensive Cancer Center

Diana Samuels

Diana Tran Samuels, PharmD, PharmD

Faculty

City of Hope National Medical Center

Aaron Rosenberg

Aaron S Rosenberg, MD

Faculty

UC Davis Comprehensive Cancer Center

Hun Lee

Hun Ju Lee, MD

Faculty

Sarah Lee

Sarah S Lee, MD, MD

Faculty

City of Hope Comprehensive Cancer Center

Maria Motta

Maria Motta, ARNP, DNP

Faculty

City of Hope

Cynthia Fu

Cynthia Fu, PharmD

Faculty

City of Hope National Medical Center

J Christine Ye

J Christine Ye, MD

Faculty

University of Texas - MD Anderson Cancer Center

Angela Fleischman

Angela Fleischman, MD, MD, PhD

Faculty

Gabriel Park

Gabriel Park, PharmD

Faculty

City of Hope Medical Center

Tamer Othman

Tamer Othman, MD

Faculty

UCSF

Brian Lee

Brian V Lee

Faculty

Jodi Lipof

Jodi Lipof, MD

Faculty

UCSF

Kwan-Keat Ang

Kwan-Keat Ang

Faculty

Conference program and agenda

Agenda

Day 1: Friday, February 27th, 2026

All timings are in Pacific Time (PDT, GMT-07:00) time.

12:30 PM - 01:30 PMRegistration, Networking, & Exhibits (Seascape Room)
01:30 PM - 02:00 PMSession 1: Plenary Lecture (Peninsula Room)

01:30 PM - 01:50 PM

Plenary Lecture Brian Sworder, MD, MD, PhD, PhD

01:50 PM - 02:00 PM

Q&A

02:00 PM - 03:15 PMSession 2: Lymphoma (Peninsula Room)

Session Chair: Matthew Mei, MD

02:00 PM - 02:15 PM

CLL - How to approach cases refractory to both a covalent BTKi and a BCL2 Inhibitor Matthew J. Cortese, MD, MPH

02:15 PM - 02:30 PM

Have we solved HL? What are the unmet needs in 2025? Harsh Shah, DO

02:30 PM - 02:45 PM

Update in R/R MZL Matthew Mei, MD

02:45 PM - 03:15 PM

Case-Based Panel Discussion Lihong Wu, MD

03:15 PM - 03:45 PMBreak & Exhibits (Seascape Room)
03:45 PM - 05:15 PMSession 3: Leukemia (Peninsula Room)

Session Chair: Vinod Pullarkat, MD; Brian A Jonas

03:45 PM - 04:00 PM

Induction for acute myeloid leukemia: Does anyone still need 7+ 3 ? Brian A Jonas

04:00 PM - 04:15 PM

Adding targeted agents to AML therapy backbone Amanda Blackmon, DO

04:15 PM - 04:30 PM

Chemotherapy or chemotherapy free : Treatment of Philadelphia positive ALL Tamer Othman, MD

04:30 PM - 04:45 PM

Who needs transplant for ALL in CR1 : Genetics vs MRD Vinod Pullarkat, MD

04:45 PM - 05:15 PM

Case-Based Panel Discussion Robert Matthew Carroll, MD

Day 2: Saturday, February 28th, 2026

07:00 AM - 08:00 AMRegistration, Breakfast, & Exhibits (Seascape Room)
08:00 AM - 08:15 AMBinaytara's Efforts in Improving Cancer Care Disparities (Peninsula Room)

Conference Chair: Justin Ryan Marquart, MBA

08:15 AM - 09:45 AMSession 4: Optimizing Frontline Treatment Multiple Myeloma (Peninsula Room)

Session Chair: Jonathan L Kaufman, MD; Michael Rosenzweig, MD

08:15 AM - 08:30 AM

Newly Diagnosed TI - Optimal Treatment in 2026 – Which regimen and for how long ? Michael Rosenzweig, MD

08:30 AM - 08:50 AM

Debate: Frontline TE in MM

08:30 AM - 08:40 AM

MRD stands for Make the Right Decision on Transplant Aaron S Rosenberg, MD

08:40 AM - 08:50 AM

MRD stands for DON’T Make the wRong Decision regarding Upfront Transplant Jodi Lipof, MD

08:50 AM - 09:05 AM

Optimal Maintenance - Which agents for SR/HR - MRD Guided? Jonathan L Kaufman, MD

09:05 AM - 09:20 AM

Evaluation and Treatment of the Frail Patient J Christine Ye, MD

09:20 AM - 09:35 AM

Triplets and ADCs – When and How to Sequence in RRMM Sarah S Lee, MD, MD

09:35 AM - 09:45 AM

Case Presentation Kwan-Keat Ang, MD, MD

09:45 AM - 10:15 AMBreak & Exhibits (Seascape Room)
10:15 AM - 11:45 AMSession 5: Leukemia II (Peninsula Room)

Session Chair: Vinod Pullarkat, MD; Jerald Radich, MD

10:15 AM - 10:30 AM

Prognostication of MDS and timing of stem cell transplant Wanxing Chai-Ho, MD

10:30 AM - 10:45 AM

MRD monitoring in AML. How and when? Jerald Radich, MD

10:45 AM - 11:00 AM

Treatment of aplastic anemia in adults: Choosing IST vs transplant Ryotaro Nakamura, MD

11:00 AM - 11:15 AM

MPN: Do available drugs provide survival benefit? Angela Fleischman, MD, MD, PhD

11:15 AM - 11:45 AM

Case-Based Panel Discussion Idoroenyi Amanam, MD; Saro Kasparian

11:45 AM - 12:30 PMSession 6: Pharmacist & APP Session: Monitoring and managing side effects of targeted agents for AML (Peninsula Room)

11:45 AM - 11:55 AM

IDH Inhibitors Diana Tran Samuels, PharmD, PharmD

11:55 AM - 12:05 PM

Menin Inhibitors Maria Motta, DNP, ARNP

12:05 PM - 12:15 PM

FLT3 Inhibitors Gabriel Park, PharmD

12:15 PM - 12:30 PM

Case-Based Panel Discussion Maria Motta, DNP, ARNP; Gabriel Park, PharmD; Diana Tran Samuels, PharmD, PharmD

12:30 PM - 01:30 PMLunch & Exhibits (Seascape Room)

Venue and map

Accreditations and continuing education

Accreditation

Registration and pricing

Exhibitors and sponsorship